George Laliotis is Featured in a New Professional Profile

Read Time:2 Minute, 55 Second

During the course of the interview, the acclaimed physician and scientist expressed some fascinating insights, ideas, and opinions.

BALTIMORE, MD / ACCESSWIRE / January 9, 2023 / When George Laliotis, a noted medical researcher, physician, scientist, and entrepreneur, was approached about becoming the featured subject of a new professional profile, he agreed readily, eager to share his accumulated wisdom with the public. The profile, which was conducted by the writing staff of an online periodical that focuses on matters relating business, leadership, and technology, was published on November 29, 2022.

At the outset of the profile, George addresses a question about how he stays engaged with his industry and cultivates his desire to acquire new knowledge, answering, “I think my hunger for knowledge comes from my interaction with the available technology, as well as environments which encourage my scientific mind. It’s just how my brain is structured, and I think it’s something that will never go away. I’m fascinated by the details about how things work, and with computing and artificial intelligence in particular. AI and big data provide an incredible way to leverage knowledge. I find them to be great stimuli in my hunger for knowledge, and I consistently harvest their findings to learn as much as possible and build on my innate curiosity.”

Later in the interview, George Laliotis is asked to share a long-term career goal that he one day hopes to achieve. “My long-term strategy is to use all the knowledge and expertise I’ve learned from the different settings in which I’ve applied myself-academics, the laboratory, the healthcare industry, the private sector-in order to help as many people as I possibly can,” he replies, before elaborating in greater detail. “Specifically, one of my major long-term career goals is to share the ability to manage oncology patients in a multidisciplinary manner. The plan goes something like this: We will begin with applying basic science in the development and identification of new pathways involving cancer. We will include research on how drugs are being developed and evaluated, and document how to treat patients. As a medical oncologist, I can develop public health policies in order to prevent the misuse of other procedures. Overall, I seek to create a more holistic approach for the patient and to help both patients and their families with all the tools at my disposal.”

George Laliotis, Monday, January 9, 2023, Press release picture

Anyone interested in reading the full text of this interview will find it located here, while anyone curious to learn more about George Laliotis is invited to visit his professional blog.

About George Laliotis:

Located in Baltimore, Maryland, George Laliotis is an innovative physician and scientist with ten years of experience in clinical medicine, medical affairs, managerial medicine, and translational and basic research, including five years of training in the United States of America. He is also certified by the Educational Commission for Foreign Medical Graduates (ECFMG). George possesses a deep knowledge of clinical indications, medical affairs, and methodologies in Internal Medicine, Hematology, and Oncology. Regarding credentials, George Laliotis has certifications from the Massachusetts Institute of Technology, Harvard University, Johns Hopkins School of Engineering, and Johns Hopkins School of Public Health. He has both informal and formal experience editing scientific manuscripts, including more than 50 as an academic proofreading editor. He has also co-authored multiple grant applications.

George Laliotis’ professional expertise centers around the regulation of RNA biology from oncogenic signaling pathways and the development of targeted RNA therapeutics.

Media Contact:

Email: [email protected]
Phone: +1 (443) 720 4731

SOURCE: George Laliotis

Happy
Happy
0 %
Sad
Sad
0 %
Excited
Excited
0 %
Sleepy
Sleepy
0 %
Angry
Angry
0 %
Surprise
Surprise
0 %
Previous post Dora Taggart, CEO of Microbial Insights, Wins the Prestigious NGWA Technology Award
Next post Context Analytics Introduces Private Company Database